Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells.
Lica JJ, Wieczór M, Grabe GJ, Heldt M, Jancz M, Misiak M, Gucwa K, Brankiewicz W, Maciejewska N, Stupak A, Bagiński M, Rolka K, Hellmann A, Składanowski A. Lica JJ, et al. Among authors: hellmann a. Int J Mol Sci. 2021 May 6;22(9):4931. doi: 10.3390/ijms22094931. Int J Mol Sci. 2021. PMID: 34066491 Free PMC article.
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma.
Róbak T, Gora-Tybor J, Krykowski E, Walewski JA, Borawska A, Pluźańska A, Potemski P, Hellmann A, Zaucha JM, Konopka L, Ceglarek B, Durźyński T, Sikorska A, Michalak K, Urasiński J, Opalińska J, Dmoszyńska A, Adamczyk-Cioch MB, Kuratowska Z, Dwilewicz-Trojaczek J, Boguradzki P, Deren M, Maj S, Grieb P. Róbak T, et al. Among authors: hellmann a. Leuk Lymphoma. 1997 Jun;26(1-2):99-105. doi: 10.3109/10428199709109163. Leuk Lymphoma. 1997. PMID: 9250793 Clinical Trial.
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
Robak T, Błasinka-Morawiec M, Krykowski E, Kasznicki M, Płuzanska A, Potemski P, Hellmann A, Zaucha JM, Lewandowski K, Dmoszynska A, Hansz J, Komarnicki M, Konopka L, Durzynski T, Ceglarek B, Sikorska A, Kotlarek-Haus S, Mazur G, Urasinski I, Zdziarska B, Maj S, Kopec I, Skotnicki AB, Dwilewicz-Trojaczek J, Grieb P, et al. Robak T, et al. Among authors: hellmann a. Leuk Lymphoma. 1996 Aug;22(5-6):509-14. doi: 10.3109/10428199609054790. Leuk Lymphoma. 1996. PMID: 8882965 Clinical Trial.
Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
Grosicki S, Holowiecki J, Kuliczkowski K, Skotnicki A, Hellmann A, Kyrcz-Krzemien S, Dmoszynska A, Sułek K, Kloczko J, Jedrzejczak WW, Warzocha K, Zdziarska B, Wierzbowska A, Pluta A, Komarnicki M, Giebel S. Grosicki S, et al. Among authors: hellmann a. Am J Hematol. 2015 Oct;90(10):904-9. doi: 10.1002/ajh.24113. Am J Hematol. 2015. PMID: 26149802 Free article. Clinical Trial.
340 results